ALK TKIs: Treatment Decisions and Adverse Event Management

Event Overview

PROGRAM *Chair: Prof Nick Pavlakis* 6:00 PM – 7:00 PM AEDT
Time	Topic	Speaker
6:00 PM – 6:10 PM	Overview & Introduction	Prof Nick Pavlakis Chair, TOGA Board of Directors Medical Oncologist and Senior Staff Specialist Royal North Shore Hospital
6:10 PM – 7:00 PM	Panel Discussion	All Speakers A/Prof Zarnie Lwin Senior Medical Oncologist Royal Brisbane and Women’s Hospital & The Prince Charles Hospital University of Queensland A/Prof Tim Clay Medical Oncologist St John of God Subiaco Hospital Dr Malinda Itchins Medical Oncologist Royal North Shore Hospital, GenesisCare, and North Shore Private A/Prof Thomas John Medical Oncologist Peter MacCallum Cancer Centre

Chair:

Prof Nick Pavlakis

Prof Nick Pavlakis has nearly 20 years’ experience in the treatment and research of thoracic and gastrointestinal cancers. He is the current Chair of the TOGA Board and has previously served on the Boards of Northern Cancer Institute and COSA.

His training and research background includes new drug development, biomarker research, clinical trials, including TOGA’s ASPiRATION study, and clinical practice guidelines development.

Nick has served on the leadership committees of numerous national/international collaborative group trials in lung cancer, mesothelioma and gastrointestinal cancers. He was involved in the development of Australian clinical practice guidelines in lung cancer and mesothelioma. He has served as faculty of the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer, its Mesothelioma task force and is current co-chair of the IASLC Continuing Medical Education Committee; and is a faculty member of the MOGA/ASCO/ACCR Australia and Asia Pacific Clinical Oncology Research Development Workshop (ACORD).

Presenters:

A/Prof Zarnie Lwin

Zarnie Lwin is an Associate Professor from the University of Queensland and is a Senior Staff Specialist Medical Oncologist at the Royal Brisbane & Women’s Hospital and The Prince Charles Hospital, Australia. She undertook a two-year clinical research fellowship in lung cancer at the Prince Margaret Cancer Centre, Toronto under the mentorship of Professor Natasha Leighl and Professor Frances Shepherd. Zarnie has been actively involved in clinical trials, research, and advocacy for the past 15 years. During this time, she has also had the privilege to serve on and Chair several national and international committees in oncology. She has a large clinical practice specialising in thoracic oncology and neurooncology. Her keen research interests include Societal Research, Health Services Research, and equity and she has won three awards for her Original Research. She currently serves as the Executive Editor for Neurooncology Practice. Zarnie is committed to global education and mentorship.

A/Prof Tim Clay

Tim is a Medical Oncologist at St John of God Subiaco Hospital in WA. He completed oncology training through the Victorian Medical Oncology Training Group and an MD at St Vincent's Hospital Melbourne and the University of Melbourne. He has a subspecialty interest in the management of thoracic malignancies and is active in clinical trials and training junior medical staff in clinical research methodology.

Dr Malinda Itchins

Dr Malinda Itchins BMedSci, MBBS(Hons1), PhD, FRACP, is a thoracic medical oncologist at Royal North Shore Hospital, GenesisCare, and North Shore Private and early career researcher and senior clinical lecturer with the University of Sydney. In 2020 she graduated from University of Sydney in her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically and clinically. Malinda is a Board Director and the Lung Cancer Chair for the Clinical Oncology of Australia (COSA), and Advanced NSCLC Co-Chair for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is Primary Investigator on several lung cancer clinical trials and her research focus to date has been in patterns of care, the real-world experience, biomarker exploration and drug resistance in lung cancer. She is passionate about the evolution of precision medicine and equity of access to care in thoracic cancers.

A/Prof Thomas John

A/Prof Thomas John is a medical oncologist specialising in Thoracic malignancies and genetics working at the Peter MacCallum hospital in Melbourne. He received his medical degree from Monash University and PhD from University of Melbourne in 2008. He completed a post-doctoral fellowship with Prof F. Shepherd and Prof M. Tsao in Toronto before returning to Melbourne.

He is a member of ASCO, ESMO, IASLC, AACR, MOGA and the Thoracic Oncology Group Australasia (TOGA), and chair of the Scientific Committee for TOGA. He is an associate editor for the Journal of Thoracic Oncology and is actively involved clinical trials and translational research into lung cancer and mesothelioma.

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript